Clinical trial
Long Term Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment…
NCT00458510 · Archimedes Development Ltd, Industry · Completed
Key facts
| NCT number | NCT00458510 |
|---|---|
| Title | Long Term Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain |
| Official title | An Open-Label Study Investigating Long-Term Safety and Tolerability of Fentanyl Citrate Nasal Spray in the Treatment of BTCP in Subjects Taking Regular Opioid Therapy |
| Lead sponsor | Archimedes Development Ltd, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cancers, Pain |
| Intervention type | Drug |
| Interventions | Fentanyl (Nasalfent, Fentanyl Citrate Nasal Spray) |
| Enrollment | 403 |
| Start date | Jan 1, 2007 |
| Primary completion | Oct 1, 2011 |
| Completion | Jul 1, 2012 |
| First posted | Apr 11, 2007 |
| Last update posted | Jul 11, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: